USPH Financials

Income Statement
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Revenue
198.3M
-2.2%
202.7M
+2.8%
197.1M
-0.1%
197.3M
+7.4%
183.8M
Cost of Revenue
0
+100.0%
-468703000
-392.5%
160.3M
0
0
Gross Profit
198.3M
-70.5%
671.4M
+1721.0%
36.9M
-81.3%
197.3M
+7.4%
183.8M
Operating Expenses
185.8M
-71.6%
654.7M
+5572.0%
11.5M
-93.3%
172.4M
+5.0%
164.1M
R&D
0
0
0
0
0
SG&A
137.8M
-71.3%
480.0M
+2656.5%
17.4M
-86.7%
131.3M
+3.0%
127.5M
Operating Income
12.5M
-25.6%
16.8M
-33.8%
25.3M
+1.6%
24.9M
+27.0%
19.6M
EBITDA
18.5M
-13.6%
21.4M
-31.3%
31.2M
+0.5%
31.0M
+21.5%
25.5M
Net Income
8.2M
-11.1%
9.2M
-48.0%
17.6M
-0.4%
17.7M
+31.6%
13.5M
EPS (Basic)
$-0.12
+72.1%
$-0.43
-189.6%
$0.48
-17.2%
$0.58
-27.5%
$0.80
EPS (Diluted)
$-0.12
+72.1%
$-0.43
-189.6%
$0.48
-17.2%
$0.58
-27.5%
$0.80
Shares (Diluted)
15.2M
+0.0%
15.2M
-0.2%
15.2M
+0.0%
15.2M
+0.4%
15.1M
US Physical Therapy (USPH) โ€” Financials